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SUMMARY
Ionotropic glutamate receptor (iGluR) trafficking and
function underpin excitatory synaptic transmission
and plasticity and shape neuronal networks. It is
well established that the transcription, translation,
and endocytosis/recycling of iGluRs are all regulated
by neuronal activity, but much less is known about
the activity dependence of iGluR transport through
the secretory pathway. Here, we use the kainate re-
ceptor subunit GluK2 as a model iGluR cargo to
show that the assembly, early secretory pathway
trafficking, and surface delivery of iGluRs are all
controlled by neuronal activity. We show that the
delivery of de novo kainate receptors is differentially
regulated by modulation of GluK2 Q/R editing,
PKC phosphorylation, and PDZ ligand interactions.
These findings reveal that, in addition to short-term
regulation of iGluRs by recycling/endocytosis and
long-term modulation by altered transcription/trans-
lation, the trafficking of iGluRs through the secretory
pathway is under tight activity-dependent control to
determine the numbers and properties of surface-
expressed iGluRs.
INTRODUCTION
The morphological complexity of neurons presents unique chal-
lenges for the timelyandappropriatesupplyofproteins todynamic
and metabolically active synapses. The ionotropic glutamate re-
ceptor (iGluR) family comprising N-methyl-D-aspartate (NMDA),
a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA),
and kainate receptors (NMDARs, AMPARs, and KARs, respec-
tively) are critical for synaptic transmission and plasticity, and
the mechanisms by which iGluRs are delivered to, retained at,
and removed from synapses under basal, stimulated, and patho-
logical conditions have been the focus of intense investigation for
decades (Huganir and Nicoll, 2013; Granger and Nicoll, 2013;
Lerma and Marques, 2013; Henley and Wilkinson, 2016).
The transcription (Liu et al., 2010; Jia et al., 2006; Grooms
et al., 2006), RNA editing (Sanjana et al., 2012), translation (Schu-
man et al., 2006), post-translational modification (Martin et al.,
2007; Copits and Swanson, 2013; Lussier et al., 2015; Wilkinson
et al., 2012; Chamberlain et al., 2012; Konopacki et al., 2011),
and surface endocytosis/recycling (Glebov et al., 2015; Boehm
et al., 2006; Palmer et al., 2005; Beattie et al., 2000; Kennedy
and Ehlers, 2011) of iGluRs are all activity-dependently regu-
lated. Surprisingly, however, relatively little is known about
whether and how the delivery of newly synthesized iGluRs
through the secretory pathway is controlled by neuronal activity.
Studies using temperature-sensitive vesicular stomatitis virus G
transmembrane protein (tsVSV-G) as a cargo marker for the en-
domembrane system have reported that endoplasmic reticulum
(ER) exit sites (ERESs) are both present and utilized in dendrites
and that some VSV-G cargo subsequently colocalizes at den-
dritic Golgi outposts (Torre and Steward, 1996; Presley et al.,
1997; Horton and Ehlers, 2003). Using mRNA trafficked from
the soma, postsynaptic proteins can be locally translated and
post-translationally modified (Cajigas et al., 2012; Holt and
Schuman, 2013; Na et al., 2016). Furthermore, transmembrane
proteins with an immature glycosylation profile can be surface-
expressed, suggesting that not all secretory pathway cargo
needs to be processed within the Golgi prior to plasma mem-
brane insertion (Hanus et al., 2016).
Despite its widespread use, the fact that tsVSV-G is an exog-
enous viral protein and that temperature shifts are required
to release it from the ER raise important questions about its
fidelity as a reporter for endogenous neuronal proteins. Despite
these caveats, neuronal activity can increase VSV-G-containing
vesicle delivery through the secretory pathway to the cell surface
(Hanus et al., 2014), suggesting, but not directly demonstrating,
that the secretory pathway trafficking of endogenous cargos
such as iGluRs is likely to be activity-dependently regulated.
Furthermore, the secretory pathway trafficking of AMPARs can
be regulated by interactions with coat protomer II (COPII)
components following activation of metabotropic glutamate re-
ceptors (Pick et al., 2017).
To directly monitor iGluR processing and progression through
the secretory pathway under basal and stimulated conditions,
we adapted the retention using selective hooks (RUSH) system
that allows the synchronous release and visualization of the
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trafficking of cargo through the secretory pathway (Boncompain
et al., 2012). We used the KAR subunit GluK2 as a prototypic
iGluR cargo. KARs are present at both pre- and postsynaptic
membranes, where they perform distinct roles in modulating
synaptic transmission, neuronal excitability, and network activity
(Contractor et al., 2011; Lerma andMarques, 2013), and they are
implicated in processes ranging from neuronal development and
Figure 1. Construction and Validation of
RUSH Glutamate Receptor Subunits in
HeLa and Primary Hippocampal Neuronal
Cells
(A) Schematic of a RUSH ionotropic glutamate re-
ceptor subunit. SBP, streptavidin-binding peptide.
(B) Representative confocal images of the AMPAR
subunits SBP-mCherry-GluA1 and SBP-EGFP-
GluA2 and the KAR subunit SBP-EGFP-GluK2 in
HeLa cells. Receptors are retained in the ER (0 min)
and synchronously released by biotin addition,
allowing trafficking to the cell surface (60 min after
biotin addition). Total, green; surface anti-SBP, red.
(C) Quantification of the data represented in (B);
three independent experiments, n = 80 cells/con-
dition. ****p < 0.0001, Welch’s t test.
(D) Representative still frames of the TIRF micro-
scopy video (Figure S1B; Movie S1), showing the
time course of trafficking and analysis of cell
surface delivery of SBP-SEP-GluK2 after biotin
addition. Arrows indicate sites of exocytosis.
Quantification of surface delivery over time is also
shown. See also Figure S1B.
(E) Representative confocal images of primary hip-
pocampal neurons showing the differential secre-
tory pathway trafficking rates of SBP-EGFP-GluK2,
SBP-mCherry-GluA1, and SBP-EGFP-GluA2 con-
taining KARs and AMPARs, respectively. Surface-
expressed receptorswerevisualizedusinganti-SBP
(red) at the indicated times (minutes) after biotin
release. White boxes positioned on the merged
panels indicate the region of the zoom panel.
(F) Quantification of the data shown in (E); three
independent experiments, n = 20–24 for each re-
ceptor per time point. ***p < 0.001, **p < 0.01,
Welch’s t test.
Scale bars, 10 mm.
differentiation to neurodegeneration and
neuronal cell death (Contractor et al.,
2011; Gonza´lez-Gonza´lez et al., 2012).
We show that KARs can use a local
dendritic secretory pathway. GluK2 edit-
ing is activity-dependently controlled,
resulting in modulation of KAR assembly
(Ball et al., 2010) and subsequent in-
creases in unedited GluK2-containing,
calcium-permeable KARs at the cell sur-
face (Egebjerg and Heinemann, 1993).
Under basal conditions, the secretory
pathway trafficking of GluK2-containing
KARs is regulated by protein kinase C
(PKC) phosphorylation. In a distinct regu-
latory process, surface KAR activation
slows the progression of newly synthesized KARs through the
secretory pathway by modulating interactions at the C-terminal
PDZ ligand of GluK2. Together, these data reveal that the
delivery of de novo KARs to the cell surface is dynamically regu-
lated in a sophisticated, multilayered manner. These mecha-
nisms provide additional flexibility to neuronal responses to
changing cellular environments and network activity.
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Figure 2. KARs Use Local Secretory Pathway Systems
(A) Schematic of dendritic local secretory pathways in neurons, focusing on ER exit sites.
(B) Representative fixed confocal images of dendritic ERESs (using the marker mRuby-Sec23a) and SBP-EGFP-GluK2 10 min after biotin addition. White arrows
in the merged panel indicate colocalization.
(C) Kymograph (Movie S2) of SBP-EGFP-GluK2 and mRuby-Sec23a up to 24 min 50 s after biotin addition, with a frame being taken every 10 s. White boxes on
the merged panel show the duration of colocalization.
(D) Schematic of dendritic local secretory pathways in neurons, focusing on the Golgi.
(E) Representative fixed confocal images of SBP-EGFP-GluK2 colocalization with the Golgi marker Sialyltransferase-mCherry (Golgi) before biotin release and a
line trace illustrating lack of colocalization along the line indicated in white in the merged image.
(F) Representative fixed confocal images of SBP-EGFP-GluK2 30 min after biotin-induced release with Sialyltransferase-mCherry (Golgi) and line trace quan-
tification.
(G) Kymograph (Movie S3) of SBP-EGFP-GluK2 and GalT-mCherry (Golgi) after biotin addition up to 59min 50 s, with a frame being taken every 10 s.White boxes
on the merged panel show colocalization duration.
Scale bars, 10 mm.
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RESULTS
Using RUSH to Assay iGluR Secretory Pathway
Trafficking
We utilized the RUSH system by tagging the GluK2 KAR subunit
and both the GluA1 and GluA2 AMPAR subunits at the N termi-
nus with a streptavidin-binding peptide (SBP) and a fluorescent
tag. When these constructs are coexpressed with a streptavi-
din-KDEL ‘‘hook’’ that localizes to the lumen of the ER, the
SBP-tagged subunits are anchored at the ER membrane (Fig-
ure 1A). The retained SBP-tagged receptors can then be syn-
chronously released by biotin addition to monitor their trafficking
through the secretory pathway (Figure S1A; Boncompain and
Perez, 2012).
We first validated these RUSH constructs in HeLa cells. As ex-
pected, the SBP-tagged receptors are efficiently retained in the
ER (0 min), and, upon addition of biotin, they are released and
move through the secretory pathway, reaching the cell surface
after 60 min (Figures 1B and 1C). Interestingly, each of the three
different subunits had different kinetics, with much more GluK2
than GluA1 or GluA2 present at the cell surface after 60 min.
Because GluK2 trafficsmost rapidly, wemeasured the dynamics
of surface expression using super-ecliptic pHluorin (SEP)-
tagged GluK2 (SBP-SEP-GluK2) (Ashby et al., 2004; Wilkinson
et al., 2014) and total internal reflection fluorescence (TIRF)
microscopy. GluK2 starts accumulating at the surface 30 min
after biotin-induced release from the ER (Figure 1D; Figure S1B;
Movie S1).
Consistent with the results from HeLa cells, we observed
different rates of secretory pathway trafficking for GluK2,
GluA1, and GluA2 in hippocampal neurons (Figures 1E and 1F).
In agreement with previous reports using endogenous subunits
(Greger et al., 2002), SBP-mCherry-GluA1 traffics through the
secretory pathway quicker than SBP-EGFP-GluA2. These data
show that the RUSH system allows synchronized release of
KARs and AMPARs from the ER in both clonal cell lines and neu-
rons and that it provides a powerful tool to investigate the early
trafficking steps of iGluRs.
KARs Use Dendritic ER Exit Sites and Golgi Outposts
VSV-G and NMDARs have been reported to use dendritic ERESs
and Golgi outposts (Figures 2A and 2D) for post-translational
modification, which is facilitated by the interacting proteins
CASK and SAP97 (Horton and Ehlers, 2003; Jeyifous et al.,
2009). Although KARs bind to both CASK and SAP97 through
a PDZ ligand/domain interaction (Coussen et al., 2002; Hirbec
et al., 2003), it is unknown whether KARs use local secretory
pathways. We therefore investigated this using SBP-EGFP-
GluK2 in neurons. SBP-EGFP-GluK2 colocalizes with mRuby-
Sec23A-labeled ERESs (Budnik and Stephens, 2009; Hughes
and Stephens, 2010) in dendrites after biotin-induced release
(Figures 2B and 2C; Figure S2A; Movie S2).
VSV-G colocalizes with local Golgi outposts after release from
dendritic ERESs (Horton and Ehlers, 2003; Figure 2D). Before
release, SBP-EGFP-GluK2 is retained in the ER and does not co-
localize with dendritic Golgi outposts (Figure 2E). However,
30 min after ER release by biotin, SBP-EGFP-GluK2 strongly co-
localized at Golgi outposts (Figures 2F and 2G; Figure S2B;
Movie S3), demonstrating that KARs utilize local secretory
pathway systems.
Assembly and Surface Delivery of Newly Synthesized
KARs Is Controlled by Chronic Changes in Synaptic
Activity and Mediated by Changes in the RNA Editing
of GluK2
NMDAR and AMPAR surface expression scales in response to
chronic down- or upregulation of synaptic activity (Rao and
Craig, 1997; Shepherd et al., 2006; Turrigiano, 2012). To address
whether KARs also scale, we chronically suppressed synaptic
activity in hippocampal neurons with tetrodotoxin (TTX) for
24 hr. As expected, TTX significantly increased GluA1-contain-
ing AMPAR surface expression and also increased GluK2-con-
taining KARs at the cell surface with no change in surface
epidermal growth factor receptors (EGFRs) (Figures 3A and
3B), indicating that chronic blockade of activity upscales
GluK2-containing KARs.
The pre-mRNAs encoding GluA2 and GluK2 can undergo
editing at a site within the channel pore that changes a
glutamine (Q) residue to an arginine (R) in the translated sub-
unit (Sommer et al., 1991). This Q/R editing alters the calcium
permeability of surface-expressed AMPARs (Burnashev et al.,
1992) and KARs (Ko¨hler et al., 1993). Q/R editing also regu-
lates AMPAR and KAR subunit assembly and ER exit (Greger
et al., 2002; Ball et al., 2010). We generated RUSH variants of
edited and unedited GluK2, and, consistent with previous
observations (Ball et al., 2010), the edited (R) form of SBP-
EGFP-GluK2 exhibited lower levels of surface expression
compared with the unedited Q form in HeLa cells after 24 hr
of biotin-induced release (Figures 3C and 3D; Figure S3A).
Furthermore, TTX decreases Q/R editing of GluK2 (Figures
3E and 3F). We hypothesized that this change in GluK2 editing
will promote KAR assembly and ER exit, resulting in increased
surface expression. To test this, we knocked down ADAR2,
the enzyme responsible for GluK2 editing (Nishikura, 2016;
Figure S3B). ADAR2 knockdown reduced GluK2 editing similar
to TTX treatment (Figure S3C) and upscaled surface GluK2 in
the absence of TTX (Figures 3G and 3H), indicating that KAR
scaling is mediated, at least in part, by activity-dependent
regulation of GluK2 Q/R editing.
PKC Phosphorylation Regulates Basal KAR Trafficking
through the Secretory Pathway
To measure the secretory pathway trafficking and surface
expression of de novo KARs without confounding issues from
endocytosis and recycling of KARs, we modified the RUSH pro-
tocol to measure all subunits that reach the cell surface by live
labeling (Figure 4A). To ensure that this live labeling protocol
faithfully reports only secretory pathway trafficking to the cell
surface and is not affected by rates of endocytosis, we exposed
SBP-EGFP-GluK2-expressing HeLa cells to kainate to promote
KAR endocytosis (Figure S4A). Comparable surface delivery
levels of SBP-EGFP-GluK2 were observed with and without kai-
nate, confirming that this procedure only reports de novo KARs
delivered by the secretory pathway (Figures 4B and 4C).
Serines 846 and 868 in the C terminus of GluK2 are phosphor-
ylated by PKC, and phosphomimetic mutations of these residues
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Figure 3. KAR ER Exit Is Regulated by Activity-Dependent Changes in RNA Editing of GluK2
(A) Representative western blots of surface-biotinylated KAR and AMPAR subunits and EGFR in hippocampal neurons. The blots show surface and total levels of
subunits with or without 24-hr treatment with 1 mM TTX to suppress synaptic activity.
(B) Quantification of immunoblots and comparison of surface-to-total ratios from six (GluA1 and EGFR) and seven (GluK2) independent experiments. *p < 0.05,
Wilcoxon matched pairs signed-rank test.
(C) SBP-EGFP-GluK2 unedited (Q) or edited (R) RUSH constructs transfected into HeLa cells with addition of biotin at the time of transfection to allow basal
expression. Surface RUSH KARs were labeled with anti-SBP for a duration of 5 min. See also Figure S3A.
(D) Quantification from (C), representative of three independent experiments (n = 90). ****p < 0.0001, Welch’s t test.
(E) RT-PCR and digestion analysis of levels of unedited and edited GluK2 with or without TTX treatment. Black arrows indicate unedited forms of GluK2.
(F) Quantification of unedited and edited GluK2 with or without TTX treatment (n = 5). *p < 0.05, Welch’s t test.
(G) Representative western blots of surface-biotinylated GluK2 and EGFR after lentiviral infection of primary hippocampal neurons with either scrambled or
ADAR2-targeting shRNA. The blots show both total and surface levels of GluK2 and EGFR after 5 days of knockdown. See also Figure S3B.
(H) Quantification of immunoblots and comparison of surface-to-total ratios from six independent experiments. *p < 0.05, Wilcoxon matched pairs signed-rank
test.
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cause ER retention (Konopacki et al., 2011). We therefore used
the RUSH assay to assess the role of GluK2 phosphorylation in
KAR trafficking through the secretory pathway. We mutated
both S846 and S868 to non-phosphorylatable alanines (SBP-
EGFP-GluK2-AA) or to phosphomimetic aspartic acid residues
(SBP-EGFP-GluK2-DD). As predicted, the AA phospho-null mu-
tant traffics more and the DD phosphomimetic mutant traffics
less efficiently to the cell surface than the wild-type SBP-EGFP-
GluK2 under non-stimulated conditions. In parallel, we tested
the effect of the PKC activator phorbol 12-myristate 13-acetate
(PMA) on surface accumulation. Consistent with the mutant
data, PMA decreased the surface expression of SBP-EGFP-
GluK2, whereas SBP-EGFP-GluK2-AA was unaffected (Figures
4D and 4E; Figure S4B). Our interpretation of these results is
that a proportion of GluK2 is basally phosphorylated by PKC in
the ER and that this provides a mechanism to regulate the ER
exit and supply of de novo KARs for delivery to the cell surface.
Activation of Surface-Expressed KARs Regulates De
Novo KAR Delivery to the Cell Surface
Our data demonstrate that, rather than being a constitutive pro-
cess, the secretory pathway trafficking of KARs is subject to strict
regulation. Under basal conditions, PKC phosphorylation limits
the supply of GluK2-containing KARs, and chronic suppression
of synaptic activity reduces Q/R editing, which promotes KAR as-
sembly and ER exit. Therefore, we next tested the effects of direct
activation of surface-expressed KARs on SBP-EGFP-GluK2 traf-
ficking.We used our previously described transient kainate appli-
cation protocol (5min, 10 mMkainate + TTX followed bywashout),
which increases KAR surface expression (Martin et al., 2008;
Gonza´lez-Gonza´lez and Henley, 2013). This transient kainate
application prior to biotin-induced SBP-EGFP-GluK2 release
from the ER caused a significant reduction in trafficking through
the secretory pathway to the cell surface (Figures 5A and 5B). In
contrast, the secretory pathway trafficking of SBP-EGFP-GluA1
was unaffected (Figures 5C and 5D). These results indicate that
transient activation of surface KARs can selectively reduce the
trafficking of de novo KARs through the secretory pathway to
control the supply of receptors available for insertion at the cell
surface (FigureS5).We initially hypothesized that phosphorylation
of S846 and S868 may mediate the kainate-evoked reduction in
the surface delivery of de novo KARs (Nasu-Nishimura et al.,
2010; Konopacki et al., 2011). Contrary to our expectations, how-
ever, secretory pathway trafficking of the non-phosphorylatable
SBP-EGFP-GluK2-AA was also significantly reduced by transient
kainate stimulation (Figures 5E and 5F). Thus, kainate regulation
of KAR secretory pathway trafficking appears to be mediated
via a mechanism other than PKC phosphorylation.
The GluK2 PDZ Ligand Is Involved in Basal and Activity-
Dependent Delivery of De Novo Receptors to the Cell
Surface
The GluK2 PDZ ligand (905ETMA908) interacts with multiple PDZ
domain-containing proteins, including SAP97, PICK1, PSD95,
GRIP, syntenin, and CASK (Coussen et al., 2002; Hirbec et al.,
2002), and inhibition of PDZ interactions using a competing pep-
tide leads to a rundown in KAR excitatory postsynaptic currents
(EPSCs) (Hirbec et al., 2003). We therefore mutated the extreme
C-terminal PDZ ligand of SBP-EGFP-GluK2 from the wild-type
sequence ETMA to EPAS, which cannot interact with PDZ
domain-containing proteins (Hirbec et al., 2003).
In HeLa cells, secretory pathway trafficking for both wild-type
SBP-EGFP-GluK2-ETMA and the PDZ ligand mutant SBP-
EGFP-GluK2-EPAS was comparable (Figures 6A and 6B; Fig-
ure S6A). Similarly, there was no difference between the wild-
type and EPAS mutant when expressed in neurons with addition
of biotin at the same time as transfection to allow continuous
release of the receptor from the ER to determine their steady-
state localization (Figures 6C and 6D; Figure S6B).
We next performed experiments corresponding to those
shown in Figure 5, where biotin was added to elicit synchronized
release of SBP-EGFP-GluK2 or SBP-EGFP-GluK2-EPAS with or
without a transient kainate stimulation prior to biotin application.
This transient kainate stimulation significantly decreased the
secretory pathway trafficking of wild-type SBP-EGFP-GluK2-
ETMA (Figures 6E and 6F). Interestingly, the secretory pathway
trafficking of SBP-EGFP-GluK2-EPAS was significantly reduced
compared with SBP-EGFP-GluK2-ETMA under basal condi-
tions. Furthermore, the secretory pathway trafficking of SBP-
EGFP-GluK2-EPAS was not further decreased by kainate appli-
cation, indicating that preventing PDZ interactions occludes the
kainate-induced reduction in secretory pathway trafficking (Fig-
ures 6Eand6F; Figure S6B). Together, these results demonstrate
that, although the GluK2 PDZ interactions do not affect the
steady-state localization of GluK2-containing KARs, they regu-
late their activity-dependent secretory pathway trafficking.
DISCUSSION
Here we show that GluK2-containing KARs use a local secretory
pathway system close to their sites of membrane delivery.
Rather than being a constitutive process, KAR traffic through
the secretory pathway is tightly and differentially regulated
under chronically suppressed, basal, and transiently stimulated
conditions.
Validation of the RUSH System in Neurons
RUSH provides a powerful system for investigating the dynamics
ofAMPARandKAR trafficking to thecell surface.Weshowthat the
RUSHGluA1 andGluA2AMPARsubunits andGluK2KAR subunit
are effectively retained at the ERmembrane and can be synchro-
nously releasedondemandbyadditionofbiotin inbothclonal cells
and primary neurons. Importantly, the rates of traffic through the
secretory pathway we measured for GluA1 and GluA2 agree well
with rates reported for endogenous AMPAR subunits monitored
by pulse-chase radiolabeling, with GluA1 trafficking more rapidly
than GluA2 (Greger et al., 2002; Greger and Esteban, 2007).
KAR Scaling Is Mediated by GluK2 Editing
AMPARs and NMDARs scale in response to a prolonged
decrease or increase in synaptic activity (Turrigiano, 2012).
Given their importance in neuronal circuit development and
both pre- and postsynaptic function (Contractor et al., 2011;
Lerma and Marques, 2013) we reasoned that it is likely that
KARs also need to be tuned in response to overall activity
changes. Consistent with this, KARs are scaled by chronic
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Figure 4. Basal PKC Phosphorylation Suppresses Surface Delivery of KARs
(A) Schematic illustrating the live labeling protocol used to exclude any contribution of changes in endocytosis. 1: hooked RUSH receptor before the addition of
biotin. 2: live label with anti-SBP antibody. 3: addition of biotin allows release of receptors and accumulation at the cell surface. 4: anti-SBP antibodies bind to
newly exposed SBP-tagged receptors. 5: a proportion of receptors internalize, but cells are permeabilized and labeled with a secondary antibody labeling all
receptors that have been surface-exposed.
(B) Representative images of the live labeling protocol showing that 100 mMKA does not change the secretory pathway delivery and extent of surface expression
of SBP-EGFP-GluK2 in HeLa cells 35 min after biotin addition. See also Figure S4A.
(C) Quantification of the data shown in (B); two independent experiments, n = 80. p > 0.05, Welch’s t test.
(D) Representative images of hippocampal neurons expressing SBP-EGFP-GluK2 WT, SBP-EGFP-GluK2 S846A/S868A, or SBP-EGFP-GluK2 S846D/S868D
30 min after biotin in the presence or absence of PMA. Total receptor distribution was measured using the EGFP tag, and surface-expressed receptors were
determined using live labeling with anti-SBP. See also Figure S4B.
(E) Quantification of three independent experiments (n = 17–22). ***p < 0.0005, **p < 0.01, *p < 0.05; Welch’s t test.
Scale bars, 10 mm.
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suppression of synaptic activity (Yan et al., 2013). We propose a
mechanism analogous to NMDAR scaling whereby changes in
RNA editing regulate the ER exit and, consequently, the availabil-
ity of new NMDARs for delivery to the surface (Mu et al., 2003).
We show that chronic suppression of synaptic activity decreases
Q/R editing of GluK2, which promotes KAR assembly, ER exit,
and delivery to the cell surface (Figure 7). This mechanism to
restrict the amount of KARs reaching the cell surface likely plays
a key role in controlling neuronal excitability, and it is notable
that transgenic mice deficient in Q/R editing display increased
seizure vulnerability (Vissel et al., 2001).
PKC Phosphorylation of GluK2 Controls Basal
Trafficking through the Secretory Pathway
Agonist activation of surface-expressed KARs causes PKC
phosphorylation of GluK2 at S846 and S868, which promotes
SUMOylation and KAR endocytosis (Martin et al., 2007;
Konopacki et al., 2011; Chamberlain et al., 2012). Further-
more, phosphomimetic serine-to-aspartate mutations of resi-
dues 846 and 868 in GluK2 impede KAR traffic to the cell sur-
face (Nasu-Nishimura et al., 2010; Konopacki et al., 2011).
Here we show that these PKC phosphorylation sites are
involved in ER exit of KARs and that preventing PKC phos-
phorylation of GluK2 by mutating S846 and S868 to alanine in-
creases basal rates of secretory pathway trafficking. Thus,
PKC phosphorylation of S846 and S868 in GluK2 exerts mul-
tiple levels of control over KAR trafficking, including regulating
the number of GluK2-containing KARs that can exit the ER and
enter the secretory pathway (Figure 7).
Transient Kainate Receptor Activation Downregulates
the Delivery of Newly Synthesized KARs
Transient KAR activation can elicit a lasting upregulation of KARs
at the cell surface because of increased recycling back to the sur-
face (Martin et al., 2008; Gonza´lez-Gonza´lez and Henley, 2013),
and this form of KAR activation can also induce long-term poten-
tiation (LTP)ofAMPARs (Petrovicet al., 2017;Sanjanaetal., 2012).
Here we show that transient kainate stimulation decreases the
supply of de novo KARs through the secretory pathway.We inter-
pret these results to indicate a negative feedbackmechanism that
can limit the extent of the increase in KAR surface expression.
Thus, following a kainate-induced increase in surface expression
of locally available KARs, the supply of new receptors is restricted
to prevent positive feedback, leading to further increases in KAR
surface expression and uncontrolled neuronal excitability and ex-
citotoxicity. This agonist-mediated regulation of KAR secretory
pathway trafficking is not due to changes in the phosphorylation
status of S846 and S868 because secretory pathway traffic of
the PKC non-phosphorylatable GluK2 mutant was also reduced
by transient kainate application. Furthermore, this regulatory sys-
tem isKAR-specificbecausekainate stimulationdoesnot regulate
the secretory pathway traffic of AMPARs.
GluK2 PDZ Interactions and the Activity-Controlled
Secretory Pathway
The PDZ ligand of GluK2 binds to an array of interacting proteins,
including PSD95, SAP97, PICK1, GRIP, CASK, and syntenin
(Coussen et al., 2002; Hirbec et al., 2003) that control many as-
pects of KAR localization and function. C-terminal truncations of
GluK2 that removed the PDZ ligand did not result in major de-
fects in trafficking in heterologous cells, indicating that the PDZ
ligand is not required for folding or ER exit (Yan et al., 2004).
Consistent with this, secretory pathway trafficking is similar for
GluK2 containing either the wild-type (ETMA) or mutated non-
binding (EPAS) PDZ ligand. Furthermore, the steady-state local-
ization of PDZ ligand mutants was also unchanged, suggesting
that, although PDZ interactions are important for the dynamics
of secretory pathway trafficking, they are not required for correct
localization of GluK2.
Disruption of the GluK2 PDZ ligand did, however, significantly
decrease basal secretory pathway trafficking in neurons, which
occluded the kainate-induced reduction of secretory pathway
trafficking. This is consistent with our previous observation that
a peptide corresponding to the PDZ ligand of GluK2 can out
compete endogenous interactions and, consequently, causes
rundown of KAR-mediated EPSCs (Hirbec et al., 2003) and
long-term depression of kainate receptor-mediated synaptic
transmission (Park et al., 2006). Both of these reductions in
KAR-mediated transmission are sustained over long periods,
and we propose that they are attributable, at least in part, to
the activity-dependent reductions in KAR secretory pathway
trafficking we describe here.
In summary, the secretory pathway trafficking of KARs occurs
through local secretory pathways using ERES in distal dendrites
and Golgi outposts. We note, however, that it has recently been
reported that KARs with an immature glycosylation state
accumulate at the cell surface, suggesting that not all KARs are
processed within the Golgi (Hanus et al., 2016). Like long-term
regulation of iGluR synthesis by transcription and translation
and short-term regulation by endocytosis and recycling of sur-
face-expressed iGluRs, the intermediate-term processes of traf-
ficking through the secretory pathway are also under tight activ-
ity-dependent control. These additional medium-term regulatory
mechanisms add further flexibility and subtlety to neuronal excit-
ability and network activity. Consistent with this general idea, the
secretory pathway trafficking of the GluA2 AMPAR subunit can
be regulated by an activity-dependent interaction with COPII
vesicle proteins during mGluR-mediated, long-term depression
(Pick et al., 2017). These findings open exciting avenues of
research into how defects in this local secretory trafficking of
KARs contribute to diseases such as epilepsy and autism, in
which misregulation of KARs have been strongly implicated.
EXPERIMENTAL PROCEDURES
Primary Neuronal Culture
Embryonic hippocampal neurons were isolated from E18 Wistar rats as
described previously (Martin and Henley, 2004). The cells were then plated
out at various densities and cultured for up to 2 weeks. Plating medium was
left on the cells for the first 24 hr: Neurobasal (Gibco) medium supplemented
with horse serum (10%), GS21 (GlobalStem), and 2 mM Glutamax. Then this
was changed to feeding medium (lacking horse serum) for the duration of
the culture. Animal care and all experimental procedures were conducted in
accordance with UK Home Office and University of Bristol guidelines.
DNA Construct Generation and Transfection
All RUSH iGluR constructs were assembled in the RUSH vector system as
described previously (Boncompain and Perez, 2013). Briefly, glutamate
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Figure 5. KAR Progress through the Secretory Pathway Is Regulated by Transient KAR Stimulation
(A) Representative images of SBP-EGFP-GluK2 without biotin (0), with biotin for 30 min (30), or with a transient 5-min pre-treatment with 10 mM kainate before
biotin addition (30+KA). Total SBP-EGFP-GluK2 was visualized with EGFP, and the surface-expressed SBP-EGFP-GluK2 was live-labeled with anti-SBP.
(B) Quantification of five independent experiments (n = 24–40). ****p < 0.0001, Welch’s t test.
(C) Representative images of SBP-EGFP-GluA1 without biotin (0), with biotin for 45 min (45), or with a transient 5-min pre-treatment with 10 mM kainate
before biotin addition (45+KA). Total SBP-EGFP-GluA1 was visualized with EGFP, and the surface-expressed SBP-EGFP-GluA1 was live-labeled with anti-SBP
antibody.
(D) Quantification of three independent experiments; n = 24 for all conditions. p > 0.05, Welch’s t test.
(E) Representative images of SBP-EGFP-GluK2 S846A/S868A, 30 min after biotin (AA 30), or with a transient 5-min pre-treatment with kainate before biotin
addition (AA 30+KA). Total SBP-EGFP-GluK2 S846A/S868Awas visualizedwith EGFP, and surface-expressed SBP-EGFP-GluK2 S846A/S868Awas live-labeled
with anti-SBP antibody.
(F) Quantification of three independent experiments; n = 15–30. ****p < 0.0001, ***p < 0.001, Welch’s t test.
Scale bars, 10 mm.
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receptors were cloned so that the fluorescent protein (FP) and the SBP were
positioned immediately after an N-terminal signal peptide (in all cases, the
interleukin-2 signal peptide was used). The structure is therefore SP-SBP-
FP-glutamate receptor. All GluK2 constructs had an additional myc tag on
the N terminus, and all SBP-EGFP-GluK2 constructs used, unless specified
otherwise, were Q-edited versions (Martin et al., 2007). The R-edited version
of SBP-EGFP-GluA2 was used throughout. For each iGluR construct, a for-
Figure 6. The PDZ Ligand of GluK2 Is
Involved in Both Basal and Activity-Depen-
dent Progression of KARs through the
Secretory Pathway
(A) Representative images of HeLa cells showing
the distributions of exogenously expressed SBP-
EGFP-GluK2-ETMA or SBP-EGFP-GluK2-EPAS
before and 30 min after addition of biotin. In
all cases, EGFP was used to visualize total
receptors, and surface-expressed KARs were
visualized by live labeling with anti-SBP antibody.
(B) Quantification of two independent experiments;
n = 40 for 0 and n = 80 for 30. p > 0.05, Welch’s t
test. See also Figure S6A.
(C) Representative images of hippocampal neu-
rons expressing SBP-EGFP-GluK2-ETMA or SBP-
EGFP-GluK2-EPAS 24 hr after addition of biotin.
EGFP was used to visualize total receptors, and
surface-expressed KARs were visualized by live
labeling with anti-SBP antibody.
(D) Quantification of three independent experi-
ments; n = 22–24. p > 0.05, Welch’s t test.
(E) Representative images of hippocampal neu-
rons expressing SBP-EGFP-GluK2-ETMA or SBP-
EGFP-GluK2-EPAS before or 30 min after addition
of biotin, with or without a transient 5-min pre-
treatment of 10 mM kainate. EGFP was used to
visualize total receptors, and surface-expressed
KARswere visualized by live labeling with anti-SBP
antibody. See also Figure S6B.
(F) Quantification of four independent experi-
ments; n = 21–32. ****p < 0.0001, ***p < 0.001,
Welch’s t test.
Scale bars, 10 mm.
ward primer was designed with an FseI restriction
site and the reverse primer with a PacI site,
followed by cloning of the PCR product using stan-
dard molecular biology techniques. QuikChange
mutagenesis was used to introduce point muta-
tions. Fluorescent tags were switched using for-
ward and reverse primers with SbfI and FseI sites,
respectively. DH5a was used to clone and amplify
DNA. A Lipofectamine 2000 method from Invitro-
gen was used to introduce DNA into hippocampal
neurons (days in vitro [DIV] 13–14) and HeLa cells.
Cells were incubated at 37C and 5% CO2 for
18–24 hr before fixation or live imaging (Boncom-
pain et al., 2012).
Virus Generation and shRNA
For ADAR2 knockdown experiments, a short
hairpin RNA (shRNA)-targeting ADAR2 (target
sequence AACAAGAAGCTTGCCAAGGCC) under
the control of an H1 promoter was cloned into a
modified form of the lentiviral vector pXLG3. Lenti-
viruses were then produced using HEK293T cells,
harvested, and added to DIV 9/10 hippocampal cells for 5 days, followed by
surface biotinylation (Rocca et al., 2017).
Live Cell Surface Labeling and Fixation
All experimentswith surface stainingwere performed using a live imaging proto-
col. RUSH-transfected hippocampal neuronsorHeLacellswere live-labeled us-
ing an anti-SBP (Millipore, monoclonal, clone 20, MAB10764) primary antibody.
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Figure 7. Model
Shown is a schematic summarizing our results.
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For activity experiments, cells were incubated for 5 min in 1 mM TTX with or
without 10 mM kainate (Tocris Bioscience) and then washed with PBS.
GYKI53655 (40 mM, Abcam) was included to block AMPARs. The PKC acti-
vator PMA (12-O-tetradecanoylphorbol-13-acetate [TPA], Cell Signaling Tech-
nology) was used at 1 mM, and DMSOwas used as a vehicle. HEPES-buffered
saline (HBS) (NaCl, 140 mM; KCl, 5mM; glucose, 15 mM; HEPES, 25 mM;
CaCl2, 1.5 mM; and MgCl2, 1.5 mM) containing D-biotin (40 mM, Sigma) was
added to the cells in the presence of the anti-SBP antibody (1/500 dilution)
for different times. The 0 time point was incubated with just anti-SBP and no
biotin but always for the longest time being tested. After completion, cells
were washed with PBS multiple times before fixing in 4% paraformaldehyde
(PFA) for 8–10 min and quenched in 100 mM glycine (Severn Biotech). Cells
were then incubated with PBS + 3% BSA (Sigma) with 0.1% Triton X-100
(Fisher Scientific) for 10 min and then with PBS + 3% BSA for a further 10 min.
For all non-live labeling experiments, themediumwas removed from cells on
the day of fixation. The cells were then washed with PBS, and methanol
(20C) was added to the cells and incubated at 20C for 4 min. The cells
were then washed in PBS.
Fixed Immunostaining and Secondary Antibody Labeling
After fixation, the cells were washed in PBS before addition of primary anti-
bodies diluted in PBS + 3% BSA for an incubation time of 60 min.
Cells were washed in PBS before adding secondary antibodies (Jackson
ImmunoResearch Laboratories), which were used at 1:400 dilution in PBS +
3% BSA. The cells were then washed again in PBS and mounted onto glass
slides using Fluoromount-G with DAPI (eBioscience).
Imaging and Analysis
A Leica SP5 confocal microscope was used to image both the total (EGFP/
mCherry) and surface (anti-SBP) fluorescence, and a surface-to-total ratio
was calculated after analysis. ImageJ was used to analyze surface-to-total ra-
tios. Multiple boxes were drawn onto proximal and secondary dendrites that
had an EGFP/mCherry signal present. The total fluorescence was measured,
and then the channel was switched to surface fluorescence to measure the
surface. A surface-to-total ratio was measured, and then an average of the
multiple box measurements gave a cell surface-to-total ratio. At least eight
cells were analyzed per experiment, and experiments were repeated at least
three times using cells from independent dissections. TIRF analysis was
done using the mCherry signal to mark the cell surface. ImageJ was used to
thenmeasure the accumulation of SEP fluorescence. Prism and eitherWelch’s
t tests (direct comparison of two time points/conditions/receptors) orWilcoxon
matched-pairs signed-rank (normalized control sample) tests were used to
determine statistical significance. Data are represented as mean, and SEM
values are used for error bars. Kymograph live imaging representations and
colocalization line traces were made using ImageJ. The scale bars used
throughout all figures represent 10 mm.
RUSH Wide-Field Imaging
A Nikon Ti microscope with a Plan Apo VC 603 oil differential interference
contrast (DIC) lens and an Andor DU-885 camera were used to acquire live
wide-field RUSH images. The heated stage was pre-heated to 37C. The cell
medium was replaced with 1 mL pre-warmed HBS. When RUSH-transfected
cells were found, biotin was added to the cells by diluting biotin to a 23working
solution inHBS. 1mLof this 23 biotin working solutionwas added to the original
1 mL of imaging medium already on the cells. The cells were imaged over time
periods of up to 60 min, with a frame being taken every 5 or 10 s.
RUSH TIRF Imaging
A Leica AM TIRF MC system attached to a Leica DMI 6000 inverted epifluor-
escence microscope was used to image the surface of cells. A 633 oil lens
was used. HBS was added to the cells, and the cells were found and focused,
and the cell surface plane (mCherry) was found using automated TIRF angles.
Frames were taken every 30 s.
Scaling, Surface Biotinylation, and Western Blot
Hippocampal neurons (DIV 14–15) plated at a density of 500,000 per well of a
6-well dish were treated with 1 mM TTX for 24 hr. All steps were performed on
ice with ice-cold buffers unless stated otherwise. After the stated treatments,
hippocampal neurons were washed twice in PBS. Surface proteins were
labeled with membrane-impermeable Sulfo-NHS-SS biotin (0.3 mg/mL,
Thermo Scientific) for 10 min on ice and washed three times with PBS.
50 mM NH4Cl was added to quench free biotin-reactive groups, and cells
were extracted with lysis buffer (50 mM Tris [pH 7.4], 150 mMNaCl, 1% Triton,
0.1% SDS, and protease inhibitor [Complete, Roche]), incubated on ice for
30 min, and centrifuged (15,000 3 g, 4C, 20 min) to remove insoluble cell
debris. For isolation of surface proteins, samples were incubated with strepta-
vidin beads (Sigma) for 90 min at 4C. Following three washes, the samples
were boiled with 23 sample buffer at 95C for 10 min, resolved by SDS-
PAGE, and immunoblotted. Antibodies used were as follows: GluA1 and
GluK2 (Millipore), glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
EGFR (Abcam), and ADAR2 (Sigma). Western blots were imaged and quanti-
fied using LI-COR Biosciences Image Studio software. The surface levels of
GluA1, GluK2, and EGFR were normalized to their respective total levels to
determine surface expression. Treated samples were normalized to their con-
trol samples.
RNA Extraction and RT-PCR
RNA samples were extracted from DIV 14 hippocampal neurons after the
stated treatments using the RNeasy Mini RNA extraction kit (QIAGEN)
following the manufacturer’s protocol. 1 mg of RNA was used per condition
and reverse-transcribed to cDNA using the RevertAid First Strand cDNA Syn-
thesis Kit following the manufacturer’s protocol (Thermo Scientific). The
following primers (spanning the M2 region of GluK2) were used, giving a
PCR product of 452 bp: GluK2 F, 50-GGTATAACCCACACCCTTGCAACC-30;
GluK2 R, 50-TGACTCCATTAAGAAAGCATAATCCGA-30. To determine the
level of GluK2 RNA editing, BbvI (New England Biolabs) digestion was used
(Bernard et al., 1999). Digestion of the PCR product was performed at 37C
for 2 hr. All of the digested product was run on 4% agarose gel, and the
ethidium bromide-stained bands were imaged using a UV transilluminator
and quantified using NIH ImageJ. To determine the level of editing, the
following formula was used: (intensity of 376 [edited] / intensity of [376 (edi-
ted) + 269 (unedited)]) 3 100. The band at 76 bp was used to determine equal
loading.
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